Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity) with eight molecules in various stages of clinical development. The company has a significant presence in branded generics markets across emerging economies including India. Its subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business.
source https://www.pharmatutor.org/content/march-2020/walk-in-interview-in-production-quality-control-quality-assurance-packing-at-glenmark-pharma
No comments:
Post a Comment